Topics

Human medicines European public assessment report (EPAR): Semglee, insulin glargine, Diabetes Mellitus, Date of authorisation: 23/03/2018, Revision: 2, Status: Authorised

10:21 EDT 2 Oct 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Semglee, insulin glargine, Diabetes Mellitus, Date of authorisation: 23/03/2018, Revision: 2, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Semglee, insulin glargine, Diabetes Mellitus, Date of authorisation: 23/03/2018, Revision: 2, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Semglee, insulin glargine, Diabetes Mellitus, Date of authorisation: 23/03/2018, Revision: 2, Status: Authorised"

Quick Search

Relevant Topic

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...